Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $13.1100 (0.77%) ($13.1100 - $13.1900) on Fri. May. 7, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.55% (three month average) | RSI | 65 | Latest Price | $13.1100(0.77%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX advances 2.6% a day on average for past five trading days. | Weekly Trend | BCRX advances 0.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XBI(44%) IBB(39%) IWO(37%) ARKK(35%) ARKG(34%) | Factors Impacting BCRX price | BCRX will decline at least -2.775% in a week (0% probabilities). VIXM(-21%) UUP(-15%) VXX(-7%) TBT(-1%) IGOV(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.775% (StdDev 5.55%) | Hourly BBV | 1.1 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $11.78(11.29%) | 10 Day Moving Average | $11.97(9.52%) | 20 Day Moving Average | $11.55(13.51%) | To recent high | -3.8% | To recent low | 42.6% | Market Cap | $2.313b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |